We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.28M
2
ADP icon
Automatic Data Processing
ADP
+$2.29M
3
AMZN icon
Amazon
AMZN
+$1.57M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.47M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.22M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NICE icon
951
Nice
NICE
$5.29B
$8.5K ﹤0.01%
108
– –
CHD icon
952
Church & Dwight Co
CHD
$23.1B
$8.35K ﹤0.01%
164
+80
+95% +$4.09K
EEMV icon
953
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
$8.31K ﹤0.01%
150
– –
ALLE icon
954
Allegion
ALLE
$13B
$8.27K ﹤0.01%
102
– –
VGK icon
955
Vanguard FTSE Europe ETF
VGK
$30B
$8.27K ﹤0.01%
+150
New +$8.18K
MTB icon
956
M&T Bank
MTB
$36.2B
$8.26K ﹤0.01%
51
-301
-86% -$47.5K
AVNS icon
957
Avanos Medical
AVNS
$1.17B
$8.25K ﹤0.01%
210
-52
-20% -$1.97K
DORM icon
958
Dorman Products
DORM
$4.01B
$8.24K ﹤0.01%
+100
New +$8.16K
RF icon
959
Regions Financial
RF
$26.3B
$8.17K ﹤0.01%
558
– –
AON icon
960
Aon
AON
$77.3B
$8.11K ﹤0.01%
61
-1
-2% -$126
CNI icon
961
Canadian National Railway
CNI
$78.3B
$8.11K ﹤0.01%
100
– –
SEMG
962
DELISTED
SEMGROUP CORPORATION
SEMG
$8.1K ﹤0.01%
300
– –
BN icon
963
Brookfield
BN
$102B
$8.04K ﹤0.01%
575
-2
-0.3% -$27
DG icon
964
Dollar General
DG
$25.9B
$7.93K ﹤0.01%
110
– –
PPL
965
PPL Corp
PPL
$27.3B
$7.92K ﹤0.01%
205
-1
-0.5% -$39
TXT icon
966
Textron
TXT
$16.6B
$7.91K ﹤0.01%
168
– –
VONG icon
967
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
$7.91K ﹤0.01%
260
-4
-2% -$120
ARAY icon
968
Accuray
ARAY
$28.4M
$7.83K ﹤0.01%
1,648
– –
NDAQ icon
969
Nasdaq
NDAQ
$51.5B
$7.79K ﹤0.01%
327
-3
-0.9% -$69
RITM icon
970
Rithm Capital
RITM
$5.09B
$7.73K ﹤0.01%
497
-1,101
-69% -$18.2K
IDCC icon
971
InterDigital
IDCC
$6.68B
$7.73K ﹤0.01%
100
– –
LBRDA icon
972
Liberty Broadband Class A
LBRDA
$4.14B
$7.63K ﹤0.01%
89
-1
-1% -$86
GNE icon
973
Genie Energy
GNE
$378M
$7.62K ﹤0.01%
1,000
– –
SNPS icon
974
Synopsys
SNPS
$71.5B
$7.61K ﹤0.01%
105
+65
+163% +$4.78K
ARLP icon
975
Alliance Resource Partners
ARLP
$3.18B
$7.56K ﹤0.01%
400
– –
37 38
39
40 41

Similar funds

PJB
Paul John Balson Marina Del Rey, California $486M AUM 78.12% 1-Year Est. Return
IVA
International Value Advisers $615M AUM 6.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.